FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline <i>BRCA</i>-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of ChemotherapyGeoffrey Kim, Richard Pazdur, Amy E. McKee et al.|Clinical Cancer Research|2015Cited by 526
Vav Transformation Requires Activation of Multiple GTPases and Regulation of Gene ExpressionTodd R. Palmby, Channing J. Der|Molecular Cancer Research|2004Cited by 26